pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
IKS-03
B-Cell Non-Hodgkin Lymphoma
Iksuda Therapeutics Ltd
0
catalysts
Preclinical
IKS-04
Bile Duct Cancer (Cholangiocarcinoma)
Iksuda Therapeutics Ltd
0
catalysts
Preclinical
IL-2 + imiquimod
imiquimod
Solid Tumor
Activate Therapeutics LLC
0
catalysts
Preclinical
IL-2106
← prev
page 107 of 271
next →
131
Pain
89
Neurology
1
Gastric Cancer
iLEAD Biomedical Science Inc
0
catalysts
Preclinical
IL-21120033
Idiopathic Pulmonary Fibrosis
iLEAD Biomedical Science Inc
0
catalysts
Phase 2
IM-101
Myasthenia Gravis
ImmunAbs Inc
0
catalysts
Phase 1
IM-1021
Diffuse Large B-Cell Lymphoma
$IMNM
Immunome Inc.
0
catalysts
Preclinical
IM-1240
Adenocarcinoma Of The Gastroesophageal Junction
$PPBT
PURPLE BIOTECH LTD.
0
catalysts
Phase 1
IM-3050
Solid Tumor
$IMNM
Immunome Inc.
0
catalysts
Phase 2
IMA-203CD8
Solid Tumor
Immatics NV
0
catalysts
IMATINIB
IMATINIB (IMATINIB)
DR REDDYS
0
catalysts
Phase 2
IMB-101
Hidradenitis Suppurativa
Navigator Medicines Inc
0
catalysts
Phase 1
IMC-002
Solid Tumor
ImmuneOncia Therapeutics Inc
0
catalysts
Preclinical
IMC-008
Gastric Cancer
Suzhou Immunofoco Biotechnology Co Ltd
0
catalysts
IMCIVREE
IMCIVREE (SETMELANOTIDE ACETATE)
1 INDICATIONS AND USAGE IMCIVREE is indicated to reduce excess body weight an…
Melanocortin receptor 4
$RYTM
RHYTHM PHARMACEUTICALS, INC.
0
catalysts
IMDELLTRA
IMDELLTRA (TARLATAMAB-DLLE)
1 INDICATIONS AND USAGE IMDELLTRA is indicated for the treatment of adult pat…
Delta-like protein 3
T cell surface glycoprotein CD3
$AMGN
AMGEN INC
0
catalysts
Phase 2
IMG-007
Atopic Dermatitis (Atopic Eczema)
$IMA
ImageneBio, Inc.
0
catalysts
IMITREX
IMITREX (SUMATRIPTAN SUCCINATE)
GlaxoSmithKline LLC
0
catalysts
IMITREX STATDOSE
IMITREX STATDOSE (SUMATRIPTAN SUCCINATE)
GlaxoSmithKline LLC
0
catalysts
IMKELDI
IMKELDI (IMATINIB ORAL)
Shorla Oncology
0
catalysts
Preclinical
IMM-004
Sickle Cell Disease
IMMvention Therapeutix Inc
0
catalysts
Phase 2
IMM-124E
Travelan
Traveler's Diarrhea
$IMRN
Immuron Ltd
0
catalysts
Preclinical
IMM-4701
Triple-Negative Breast Cancer (TNBC)
ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
0
catalysts
Phase 2
IMM01-STEM
Muscle Atrophy
Immunis Inc
0
catalysts
Phase 3
IMNN-001
Epithelial Ovarian Cancer
$IMNN
Imunon, Inc.
0
catalysts
Phase 2
IMNN-101
Coronavirus Disease 2019 (COVID-19)
$IMNN
Imunon, Inc.
0
catalysts
Phase 2
IMP-1734
Fallopian Tube Cancer
$EIKN
Eikon Therapeutics, Inc.
0
catalysts
Phase 2
IMP-9064
Solid Tumor
IMPACT Therapeutics Inc
0
catalysts
IMPLANON
IMPLANON (ETONOGESTREL)
HIV infection
Progesterone receptor
$OGN
Organon & Co.
0
catalysts
Phase 2
IMS-001
Primary Progressive Multiple Sclerosis (PPMS)
Imstem Biotechnology Inc
0
catalysts
